Patient Care COVID-19 Podcasts
Four months before she fell ill with COVID-19, Harper Powell stood atop the podium at the USA Cycling Mountain Bike National Championships, sporting the stars-and-stripes jersey she won for the women’s club category.
Taking a first look at COVID-19’s effects on children and adolescents with Type 1 diabetes (T1D), researchers have linked ethnic minority status, poor blood-sugar control and diabetic ketoacidosis (DKA) with increased hospitalization.
Innovation Campus Life Education
You probably remember where you were when everything shut down in March last year. Maybe you were watching the NBA games, or perhaps you recall the White House press conferences. It’s been over a year since COVID-19, social distancing and quarantine became part of our daily vocabulary.
Debra Melani | 
April 28, 2021
Taking a first look at COVID-19’s effects on children and adolescents with Type 1 diabetes (T1D), researchers have linked ethnic minority status, poor blood-sugar control and diabetic ketoacidosis (DKA) with increased hospitalization.
Part of the risk is behavioral: Children pick up eating habits from their parents. Also, being exposed to deficits of some nutrients and excess calories in utero—particularly from fats and carbohydrates—can cause changes in gene expression that “trigger all sorts of pathogenic pathways including promoting obesity,” says Dana Dabelea, a professor of epidemiology and pediatrics at the Colorado School of Public Health, Anschutz Medical Campus. These epigenetic changes can affect the development of children’s fat tissue and when they feel full, she says.
So, for experts such as Elizabeth Carlton, an epidemiologist at the Colorado School of Public Health, the message is clear: The dents that the variants can inflict in the vaccines’ armor are relatively small. “You are far better off vaccinated if those variants are circulating than if you are unvaccinated,” Carlton said.
In this series, recognized experts from the University of Colorado's Severe Asthma Clinic and Comprehensive Lung and Breathing Program explain the implications of recently approved monoclonal antibodies for the treatment of severe eosinophilic asthma. They explain the value of recognizing the heterogeneity of asthma and the need for correct diagnosis of this troubling subtype as early as possible. Although new and emerging therapies show a promising reduction in disease burden, specialists say that equity and access issues still thwart their efforts to provide these benefits to every patient.
“We were able to determine that she had the triggers in her bloodstream that would suggest that it comes from the vaccine,” said Dr. R. Todd Clark, assistant professor of emergency medicine at the University of Colorado School of Medicine. Dr. Clark knew the Centers for Disease Control and Prevention had warned against standard blood clot medicine to treat the side effect, but no alternative was clear. “We made the call for Bivalirudin based off of the best available evidence,” Dr. Clark said.
CU Anschutz Newsroom